Paip2 inhibitors represent a distinct class of chemical compounds designed to specifically target and inhibit Poly(A) Binding Protein Interacting Protein 2 (Paip2). Paip2 plays a pivotal role in regulating mRNA translation by interacting with poly(A) binding proteins (PABPs), which are critical for maintaining the stability and efficiency of mRNA translation. Inhibitors targeting Paip2 are characterized by their molecular architecture, which allows them to bind selectively to Paip2, disrupting its interaction with PABPs. This selective binding is achieved through the careful design of these molecules, which often involves the mimicry or antagonism of Paip2's natural binding sites. The chemical structure of Paip2 inhibitors typically includes specific functional groups and moieties tailored to interact with key domains of the Paip2 protein, such as those involved in PABP binding.
The development and exploration of Paip2 inhibitors encompass a range of sophisticated chemical and biological techniques. These include high-throughput screening to identify inhibitory compounds, followed by iterative chemical synthesis and modification to enhance selectivity and binding affinity. Structural biology methods, such as X-ray crystallography or NMR spectroscopy, are employed to elucidate the precise molecular interactions between Paip2 inhibitors and the Paip2 protein. This detailed understanding aids in refining the inhibitors' design, making them more effective in binding to Paip2. Additionally, computational modeling plays a crucial role in predicting how modifications to the chemical structure of these inhibitors will impact their interaction with Paip2, guiding the synthesis of more effective compounds. The physicochemical properties of Paip2 inhibitors, like solubility, stability, and molecular weight, are also critical factors in their development. These properties are optimized to ensure efficient interaction with the Paip2 protein, enhancing the overall efficacy of the inhibitors in a cellular context without affecting their stability and solubility.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90, potentially destabilizing its client proteins and affecting the stability of proteins that regulate Paip2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter signaling pathways and may indirectly decrease Paip2 transcription. | ||||||
SN 38 | 86639-52-3 | sc-203697 sc-203697A sc-203697B | 10 mg 50 mg 500 mg | $119.00 $342.00 $883.00 | 19 | |
SN 38 is an active metabolite of irinotecan that inhibits Topoisomerase I, potentially leading to reduced transcription of Paip2. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG selectively inhibits Hsp90, which might affect protein folding and the stability of factors that regulate Paip2. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits Topoisomerase II, which can lead to DNA damage and potentially downregulate Paip2 expression. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $61.00 $153.00 $231.00 $505.00 | 1 | |
Kenpaullone is a cyclin-dependent kinase inhibitor that may alter cell cycle progression and Paip2 gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate a variety of signaling pathways and might influence transcription factors related to Paip2 expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during protein translation, which could lead to cellular stress affecting Paip2 expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor, which might influence cell cycle-dependent expression of Paip2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may modify signaling pathways relevant to the regulation of Paip2. | ||||||